News & Analysis as of

Healthcare Reform Life Sciences Innovation

A&O Shearman

The future of the robotics metaverse in the healthcare sector

A&O Shearman on

On 26 February 2025, the European Economic and Social Committee (EESC) adopted an opinion addressing the integration of robotics and the metaverse in healthcare. This forward-looking document outlines the opportunities and...more

Davis Wright Tremaine LLP

Project W: The Price of Survival Should Not Be Pain and Suffering

Project W alumna Carole Spangler Vaughn has spent her entire career in the life sciences industry working on solutions to prevent and treat diseases. When Carole was diagnosed with breast cancer and underwent chemotherapy,...more

Epstein Becker & Green

Video: Health Care's Past, Present, and Future - Diagnosing Health Care Podcast

Epstein Becker & Green on

In celebration of the 50th episode of our Diagnosing Health Care podcast, we’re looking at how the past 50 years of health law will impact health care in the next 50 years. On this episode, Epstein Becker Green attorneys...more

McDermott Will & Schulte

[Ongoing Program] Precision Health: Trends And Future Potential - Provider Perspectives on Precision Partnering - June 29th, 12:30...

Precision health has the potential to dramatically transform the healthcare landscape by developing cutting-edge solutions that significantly improve patient outcomes. Now, following its contributions to the groundbreaking...more

Morgan Lewis

What the Future May Hold for Pharma Regulation Under the Biden Administration

Morgan Lewis on

Under President Joe Biden, pharmaceutical regulation may see increased FDA guidance, new strategies to speed up innovation and regulatory review, and a renewed focus on diseases with unmet needs, among other expectations....more

McDermott Will & Schulte

[Virtual Event] 2021 J.P. Morgan Healthcare Conference - Healthcare Private Equity (PE) Leaders Forum - January 12th, 12:00 pm -...

You won’t want to miss four days of exclusive, virtual events that bring together industry leaders, emerging standouts, innovators and investors from across the industry landscape at the largest healthcare investment...more

Foley & Lardner LLP

Three Pressing Challenges for Personalized Medicine

Foley & Lardner LLP on

Personalized medicine can be described as the science of targeted therapies. Advances in diagnostic and molecular medicine have made it possible to more precisely identify alternative treatment options for patients based on...more

7 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide